We also conclude that COX-1 and COX-2 modulate resistance to EPA by altering sensitivity of CRC cells themselves to EPA, rather than by a mechanism including enhancement of the host anti-tumour immune response. This evidence concerns the gene PTGS1 and colorectal carcinoma.